Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.

Rheumatoid arthritis (RA) is associated with certain MHC class II alleles and is characterized by a chronic autoimmune response in the joints. Using transgenic mice expressing human DR4 (DRB1*0401) and human CD4, but lacking endogenous MHC class II, we show that posttranslational glycosylation of ty...

Full description

Bibliographic Details
Main Authors: Bäcklund, J, Carlsen, S, Höger, T, Holm, B, Fugger, L, Kihlberg, J, Burkhardt, H, Holmdahl, R
Format: Journal article
Language:English
Published: 2002
_version_ 1797100985391251456
author Bäcklund, J
Carlsen, S
Höger, T
Holm, B
Fugger, L
Kihlberg, J
Burkhardt, H
Holmdahl, R
author_facet Bäcklund, J
Carlsen, S
Höger, T
Holm, B
Fugger, L
Kihlberg, J
Burkhardt, H
Holmdahl, R
author_sort Bäcklund, J
collection OXFORD
description Rheumatoid arthritis (RA) is associated with certain MHC class II alleles and is characterized by a chronic autoimmune response in the joints. Using transgenic mice expressing human DR4 (DRB1*0401) and human CD4, but lacking endogenous MHC class II, we show that posttranslational glycosylation of type II collagen (CII) influences the level of T cell tolerance to this candidate cartilage-specific autoantigen. In such mice, the expression of human CII resulted in a tolerized murine T cell response to human CII. However, tolerance induction remained incomplete, preferentially deleting responses to the nonmodified CII 263-270 epitope, whereas T cell recognition of a glycosylated variant of this epitope was affected to a lesser degree. A similar dominance of T cell responses to CII-glycopeptides was recorded in a cohort of severely affected RA-patients (n = 14). Thus, RA T cells predominantly recognize the immunodominant CII peptide in its glycosylated form and may explain why previously it has been difficult to detect T cell responses to CII in RA patients.
first_indexed 2024-03-07T05:45:27Z
format Journal article
id oxford-uuid:e7128996-91f8-4744-97ce-7f6c0a34ebc2
institution University of Oxford
language English
last_indexed 2024-03-07T05:45:27Z
publishDate 2002
record_format dspace
spelling oxford-uuid:e7128996-91f8-4744-97ce-7f6c0a34ebc22022-03-27T10:35:45ZPredominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e7128996-91f8-4744-97ce-7f6c0a34ebc2EnglishSymplectic Elements at Oxford2002Bäcklund, JCarlsen, SHöger, THolm, BFugger, LKihlberg, JBurkhardt, HHolmdahl, RRheumatoid arthritis (RA) is associated with certain MHC class II alleles and is characterized by a chronic autoimmune response in the joints. Using transgenic mice expressing human DR4 (DRB1*0401) and human CD4, but lacking endogenous MHC class II, we show that posttranslational glycosylation of type II collagen (CII) influences the level of T cell tolerance to this candidate cartilage-specific autoantigen. In such mice, the expression of human CII resulted in a tolerized murine T cell response to human CII. However, tolerance induction remained incomplete, preferentially deleting responses to the nonmodified CII 263-270 epitope, whereas T cell recognition of a glycosylated variant of this epitope was affected to a lesser degree. A similar dominance of T cell responses to CII-glycopeptides was recorded in a cohort of severely affected RA-patients (n = 14). Thus, RA T cells predominantly recognize the immunodominant CII peptide in its glycosylated form and may explain why previously it has been difficult to detect T cell responses to CII in RA patients.
spellingShingle Bäcklund, J
Carlsen, S
Höger, T
Holm, B
Fugger, L
Kihlberg, J
Burkhardt, H
Holmdahl, R
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
title Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
title_full Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
title_fullStr Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
title_full_unstemmed Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
title_short Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
title_sort predominant selection of t cells specific for the glycosylated collagen type ii epitope 263 270 in humanized transgenic mice and in rheumatoid arthritis
work_keys_str_mv AT backlundj predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis
AT carlsens predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis
AT hogert predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis
AT holmb predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis
AT fuggerl predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis
AT kihlbergj predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis
AT burkhardth predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis
AT holmdahlr predominantselectionoftcellsspecificfortheglycosylatedcollagentypeiiepitope263270inhumanizedtransgenicmiceandinrheumatoidarthritis